REFERENCES
1. McDowell HP. Update on childhood rhabdomyosarcoma. Arch Dis Child.
2003;88: 354-357.
2. Arndt C, Rodeberg D, Breitfeld PP, Raney RB, Ullrich F, Donaldson S.
Does bladder preservation (as a surgical principle) lead to retaining
bladder function in bladder/prostate rhabdomyosarcoma? Results from
intergroup rhabdomyosarcoma study iv. J Urol. 2004;171: 2396-2403.
3. Kirsch CH, Goodman M, Esiashvili N. Outcome of female pediatric
patients diagnosed with genital tract rhabdomyosarcoma based on analysis
of cases registered in SEER database between 1973 and 2006. Am J Clin
Oncol. 2014;37: 47-50.
4. Minard-Colin V, Walterhouse D, Bisogno G, Martelli H, Anderson J,
Rodeberg DA, Ferrari A, Jenney M, Wolden S, De Salvo G, Arndt C, Merks
JHM, Gallego S, Schwob D, Haie-Meder C, Bergeron C, Stevens MCG, Oberlin
O, Hawkins D; International Society of Pediatric Oncology Sarcoma
Committee, the Children´s Oncology Group, the Italian Cooperative Soft
Tissue Sarcoma Group, and the European pediatric Soft tissue sarcoma
Study Group. Localized vaginal/uterine rhabdomyosarcoma-results of a
pooled analysis from four international cooperative groups. Pediatr
Blood Cancer. 2018;65: e27096.
5. Corpron CA, Andrassy RJ, Hays DM, Raney RB, Wiener ES, Lawrence W,
Lobe TE, Maurer HM. Conservative management of uterine pediatric
rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study
III and IV pilot. J Pediatr Surg. 1995;30: 942-944.
6. de Lambert G, Haie-Meder C, Guerin F, Boubnova J, Martelli H. A new
surgical approach of temporary ovarian transposition for children
undergoing brachytherapy: technical assessment and dose evaluation. J
Pediatr Surg. 2014;49: 1177-1180.
7. Martelli H, Oberlin O, Rey A, Godzinski J, Spicer RD, Bouvet N,
Haie-Meder C, Terrier-Lacombe MJ, Sanchez de Toledo J, Spooner D,
Sommelet D, Flamant F, Stevens MC. Conservative treatment for girls with
nonmetastatic rhabdomyosarcoma of the genital tract: A report from the
Study Committee of the International Society of Pediatric Oncology. J
Clin Oncol. 1999;17: 2117-2122.
8. Walterhouse DO, Meza JL, Breneman JC, Donaldson SS, Hayes-Jordan A,
Pappo AS, Arndt C, Raney RB, Meyer WH, Hawkins DS. Local control and
outcome in children with localized vaginal rhabdomyosarcoma: a report
from the Soft Tissue Sarcoma committee of the Children’s Oncology Group.
Pediatr Blood Cancer. 2011;57: 76-83.
9. Arndt CA, Donaldson SS, Anderson JR, Andrassy JR, Andrassy RJ, Laurie
F, Link MP, Raney RB, Maurer HM, Crist WM. What constitutes optimal
therapy for patients with rhabdomyosarcoma of the female genital tract?
Cancer. 2001;91: 2454-2468.
10. Million L, Anderson J, Breneman J, Hawkins DS, Laurie F, Michalski
J, Rodeberg D, Wharam M, Wolden S, Donaldson SS, Soft Tissue Sarcoma
Committee of the Children´s Oncology Group. Influence of noncompliance
with radiation therapy protocol guidelines and operative bed recurrences
for children with rhabdomyosarcoma and microscopic residual disease: a
report from the Children’s Oncology Group. Int J Radiat Oncol Biol Phys.
2011;80(2): 333-338.
11. Schuck A, Mattke AC, Schmidt B, Kunz DS, Harms D, Knietig R, Treuner
J, Koscielniak E. Group II rhabdomyosarcoma and rhabdomyosarcomalike
tumors: is radiotherapy necessary? J Clin Oncol. 2004;22: 143-149.
12. Raney RB, Walterhouse DO, Meza JL, Andrassy RJ, Breneman JC, Crist
WM, Maurer HM, Meyer WH, Parham DM, Anderson JR. Results of the
Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using
vincristine and dactinomycin with or without cyclophosphamide and
radiation therapy, for newly diagnosed patients with low-risk embryonal
rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the
Children’s Oncology Group. J Clin Oncol. 2011;29: 1312-1318.
13. Walterhouse DO, Pappo AS, Meza JL, Breneman JC, Hayes-Jordan AA,
Parham DM, Cripe TP, Anderson JR, Meyer WH, Hawkins DS. Shorter-duration
therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide
with or without radiotherapy for patients with newly diagnosed low-risk
rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the
Children’s Oncology Group. J Clin Oncol. 2014;32: 3547-3552.
14. Walterhouse DO, Pappo AS, Meza JL, Breneman JC, Hayes-Jordan AA,
Parham DM, Cripe TP, Anderson JR, Meyer HM, Hawkins DS. Reduction of
cyclophosphamide dose for patients with subset 2 low-risk
rhabdomyosarcoma is associated with an increased risk of recurrence: A
report from the Soft Tissue Sarcoma Committee of the Children’s Oncology
Group. Cancer. 2017;123: 2368-2375.
15. Ortega JA, Rowland J, Monforte H, Malogolowkin M, Triche T. Presence
of well-differentiated rhabdomyoblasts at the end of therapy for pelvic
rhabdomyosarcoma: implications for the outcome. J Pediatr Hematol Oncol.
2000;22: 106-111.
16. Nasioudis D, Alevizakos M, Chapman-Davis E, Witkin SS, Holcomb K.
Rhabdomyosarcoma of the lower female genital tract: an analysis of 144
cases. Arch Gynecol Obstet. 2017;296: 327-334.
17. Flamant F, Gerbaulet A, Nihoul-Fekete C, Valteau-Couanet D,
Chassagne D, Lemerle J. Long-term sequelae of conservative treatment by
surgery, brachytherapy, and chemotherapy for vulval and vaginal
rhabdomyosarcoma in children. J Clin Oncol. 1990;8: 1847-1853.
18. Fuchs J, Paulsen F, Bleif M, Lamprecht U, Weidner N, Zips D,
Neunhoeffer F, Seitz G. Conservative surgery with combined high dose
rate brachytherapy for patients suffering from genitourinary and
perianal rhabdomyosarcoma. Radiother Oncol. 2016;121: 262-267.
19. Gerbaulet A, Haie C, Michel G, Castaigne D, Prade M, Kunkler I, Pomp
J, Masselot J, Lhomme C, Chassagne D. Combined radio-surgical treatment
in early invasive cervix carcinoma according to prognostic factors.
Experience of the Gustave-Roussy Institute. Eur J Gynaecol Oncol.
1992;13: 256-261.
20. Levy A, Martelli H, Fayech C, Minard-Colin V, Dumas I, Gensse MC, Le
Deley MC, Oberlin O, Haie-Meder C. Late toxicity of brachytherapy after
female genital tract tumors treated during childhood: Prospective
evaluation with a long-term follow-up. Radiother Oncol. 2015;117:
206-212.
21. Magne N, Oberlin O, Martelli H, Gerbaulet A, Chassagne D, Haie-Meder
C. Vulval and vaginal rhabdomyosarcoma in children: update and
reappraisal of Institut Gustave Roussy brachytherapy experience. Int J
Radiat Oncol Biol Phys. 2008;72: 878-883.
22. Ortega JA. A therapeutic approach to childhood pelvic
rhabdomyosarcoma without pelvic exenteration. J Pediatr. 1979;94:
205-209.
23. Rodeberg DA, Stoner JA, Hayes-Jordan A, Kao SC, Wolden SL, Qualman
SJ, Meyer WH, Hawkins DS. Prognostic significance of tumor response at
the end of therapy in group III rhabdomyosarcoma: a report from the
children’s oncology group. J Clin Oncol. 2009;27: 3705-3711.
24. Kayton ML, Wexler LH, Lewin SN, Park KJ, La Quaglia MP, Abu-Rustum
NR. Pediatric radical abdominal trachelectomy for anaplastic embryonal
rhabdomyosarcoma of the uterine cervix: an alternative to radical
hysterectomy. J Pediatr Surg. 2009;44: 862-867.
25. Willows K, Lennox G, Covens A. Fertility-sparing management in
cervical cancer: balancing oncologic outcomes with reproductive success.
Gynecol Oncol Res Pract. 2016;3: 9.
26. Bouchard-Fortier G, Kim RH, Allen L, Gupta A, May T.
Fertility-sparing surgery for the management of young women with
embryonal rhabdomyosarcoma of the cervix: A case series. Gynecol Oncol
Rep. 2016;18: 4-7.
27. van Dorp W, Mulder RL, Kremer LC, Hudson MM, van den Heuvel-Eibrink
MM, van den Berg MH, Levine JM, van Dulmen-den Broeder E, di Iorgi N,
Albanese A, Armenian SH, Bhatia S, Constine LS, Corrias A, Deans R,
Dirksen U, Gracia CR, Hjorth L, Kroon L, Lambalk CB, Landier W, Levitt
G, Leiper A, Meacham L, Mussa A, Neggers SJ, Oeffinger KC, Revelli A,
van Santen HM, Skinner R, Toogood A, Wallace WH, Haupt R.
Recommendations for Premature Ovarian Insufficiency Surveillance for
Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A
Report From the International Late Effects of Childhood Cancer Guideline
Harmonization Group in Collaboration With the PanCareSurFup Consortium.
J Clin Oncol. 2016;34: 3440-3450.
28. Chow EJ, Stratton KL, Leisenring WM, Oeffinger KC, Sklar CA,
Donaldson SS, Ginsberg JP, Kenney LB, Levine JM, Robison LL,
Shnorhavorian M, Stovall M, Armstrong GT, Green DM. Pregnancy after
chemotherapy in male and female survivors of childhood cancer treated
between 1970 and 1999: a report from the Childhood Cancer Survivor Study
cohort. Lancet Oncol. 2016;17: 567-576.
29. Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS,
Wallace WH, Wang ET, Loren AW. Fertility Preservation in Patients With
Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2018;36:
1994-2001.
30. Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens
AC, Donaldson SS, Byrne J, Robinson LL. Fertility of female survivors of
childhood cancer: a report from the childhood cancer survivor study. J
Clin Oncol. 2009;27: 2677-2685.
31. Green DM, Nolan VG, Goodman PJ, Whitton JA, Srivastava DK,
Leisenring WM, Neglia JP, Sklar CA, Kaste SC, Hudson MM, Diller LR,
Stovall M, Donaldson SS, Robison LL. The cyclophosphamide equivalent
dose as an approach for quantifying alkylating agent exposure: a report
from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2014;61:
53-67.
32. Corkum KS, Rhee DS, Wafford QE, Demeestere I, Dasgupta R,
Baertschiger R, Malek MM, Aldrink JH, Heaton TE, Weil BR, Madonna MB,
Lautz TB. Fertility and hormone preservation and restoration for female
children and adolescents receiving gonadotoxic cancer treatments: A
systematic review. J Pediatr Surg. 2019; 54(11):2200-09.
33. Metzger ML, Meacham LR, Patterson B, Patterson B, Casillas JS,
Constine LS, Hijiya N, Kenney LB, Leonard M, Lockart BA, Likes W, Green
DM. Female reproductive health after childhood, adolescent, and young
adult cancers: guidelines for the assessment and management of female
reproductive complications. J Clin Oncol. 2013;31: 1239-1247.
34. Moawad NS, Santamaria E, Rhoton-Vlasak A, Lightsey JL. Laparoscopic
Ovarian Transposition Before Pelvic Cancer Treatment: Ovarian Function
and Fertility Preservation. J Minim Invasive Gynecol. 2017;24: 28-35.
35. Fernandez-Pineda I, Davidoff AM, Lu L, Rao BN, Wilson CL, Srivastava
DK, Klosky JL, Metzger ML, Krasin MJ, Ness KK, Pui CH, Robison LL,
Hudson MM, Sklar CA, Green DM, Chemaitilly W. Impact of ovarian
transposition before pelvic irradiation on ovarian function among
long-term survivors of childhood Hodgkin lymphoma: A report from the St.
Jude Lifetime Cohort Study. Pediatr Blood Cancer. 2018;65(9): e27232.